A Randomized, Controlled Trial of Intranasal Oxytocin as an Adjunct to Behavioral Therapy for Autism Spectrum Disorder

NCT01914939 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
92
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Massachusetts General Hospital

Collaborators